Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-04 · accession 0001209191-21-059526 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | 2021-10-04 | CCCC | Dubin Glenn | Dir | A - Grant | $44.99 | +138 | 295 | +88% | +$6,209 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | A | A | 138 | $44.99 | 295 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. |